increased intraocular pressure (IOP)

From Aaushi
Jump to navigation Jump to search

Etiology

Pathology

Management

More general terms

Additional terms

References

  1. Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 66
  2. Medical Knowledge Self Assessment Program (MKSAP) 11, 16. American College of Physicians, Philadelphia 1998, 2012
  3. 3.0 3.1 Journal Watch 22(15):115, 2002
    Kass MA et al The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delay or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701, 2002 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12049574
    Gordon MO et al The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120:714, 2002 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12049574
    Palmberg P Answers from the ocular hypertension treatment study. Arch Ophthalmol 120:829, 2002 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12049591
  4. 4.0 4.1 Geriatric Review Syllabus, 8th edition (GRS8) Durso SC and Sullivan GN (eds) American Geriatrics Society, 2013
    Geriatric Review Syllabus, 9th edition (GRS9) Medinal-Walpole A, Pacala JT, Porter JF (eds) American Geriatrics Society, 2016
  5. 5.0 5.1 Kymes SM, Plotzke MR, Kass MA, Boland MV, Gordon MO. Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension. Arch Ophthalmol. 2010 May;128(5):613-8. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20457984
  6. Boey PY, Mansberger SL. Ocular hypertension: an approach to assessment and management. Can J Ophthalmol. 2014 Dec;49(6):489-96. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25433737